These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7830069)

  • 1. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.
    Bierer LM; Haroutunian V; Gabriel S; Knott PJ; Carlin LS; Purohit DP; Perl DP; Schmeidler J; Kanof P; Davis KL
    J Neurochem; 1995 Feb; 64(2):749-60. PubMed ID: 7830069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
    Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
    Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia.
    Sakurada T; Alufuzoff I; Winblad B; Nordberg A
    Brain Res; 1990 Jun; 521(1-2):329-32. PubMed ID: 1698512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic markers in elderly patients with early signs of Alzheimer disease.
    Davis KL; Mohs RC; Marin D; Purohit DP; Perl DP; Lantz M; Austin G; Haroutunian V
    JAMA; 1999 Apr; 281(15):1401-6. PubMed ID: 10217056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide abnormalities in patients with early Alzheimer disease.
    Davis KL; Mohs RC; Marin DB; Purohit DP; Perl DP; Lantz M; Austin G; Haroutunian V
    Arch Gen Psychiatry; 1999 Nov; 56(11):981-7. PubMed ID: 10565496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease.
    Huberman M; Sredni B; Stern L; Kott E; Shalit F
    J Neurol Sci; 1995 Jun; 130(2):161-4. PubMed ID: 8586980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex.
    Gabriel SM; Davidson M; Haroutunian V; Powchik P; Bierer LM; Purohit DP; Perl DP; Davis KL
    Biol Psychiatry; 1996 Jan; 39(2):82-91. PubMed ID: 8717605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease.
    Sabbagh MN; Reid RT; Corey-Bloom J; Rao TS; Hansen LA; Alford M; Masliah E; Adem A; Lloyd GK; Thal LJ
    J Neural Transm (Vienna); 1998; 105(6-7):709-17. PubMed ID: 9826113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuromodulators and Alzheimer's disease].
    Vallet PG; Bouras C
    Encephale; 1988; 14(5):345-51. PubMed ID: 2463900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.
    Garcia-Alloza M; Gil-Bea FJ; Diez-Ariza M; Chen CP; Francis PT; Lasheras B; Ramirez MJ
    Neuropsychologia; 2005; 43(3):442-9. PubMed ID: 15707619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease-associated protein.
    Nemeroff CB; Bissette G; Slotkin TA; Seidler FJ; Miller BE; Ghanbari H
    Ann N Y Acad Sci; 1991; 640():193-6. PubMed ID: 1685644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dementia rating scale performance: a comparison of vascular and Alzheimer's dementia.
    Lukatela KA; Cohen RA; Kessler HA; Jenkins MA; Moser DJ; Stone WF; Gordon NF; Kaplan RF
    J Clin Exp Neuropsychol; 2000 Aug; 22(4):445-54. PubMed ID: 10923054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
    Reinikainen KJ; Soininen H; Riekkinen PJ
    J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale.
    Sultzer DL; Levin HS; Mahler ME; High WM; Cummings JL
    J Am Geriatr Soc; 1992 Jun; 40(6):549-55. PubMed ID: 1587970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical cholinergic markers in schizophrenia.
    Haroutunian V; Davidson M; Kanof PD; Perl DP; Powchik P; Losonczy M; McCrystal J; Purohit DP; Bierer LM; Davis KL
    Schizophr Res; 1994 May; 12(2):137-44. PubMed ID: 8043524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (3H)hemicholinium-3 binding sites in postmortem brains of human patients with Alzheimer's disease and multi-infarct dementia.
    Kristofiková Z; Fales E; Majer E; Klaschka J
    Exp Gerontol; 1995; 30(2):125-36. PubMed ID: 8591807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease.
    Perry EK; McKeith I; Thompson P; Marshall E; Kerwin J; Jabeen S; Edwardson JA; Ince P; Blessed G; Irving D
    Ann N Y Acad Sci; 1991; 640():197-202. PubMed ID: 1723256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
    Huang W; Alexander GE; Chang L; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Neurology; 2001 Aug; 57(4):626-32. PubMed ID: 11524470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
    Perry RH; Perry EK; Smith CJ; Xuereb JH; Irving D; Whitford CA; Candy JM; Cross AJ
    J Neural Transm Suppl; 1987; 24():131-6. PubMed ID: 2824687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density.
    Samuel W; Alford M; Hofstetter CR; Hansen L
    J Neuropathol Exp Neurol; 1997 May; 56(5):499-508. PubMed ID: 9143263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.